NIH-funded research NIH-funded research

Reducing cardiovascular risks in young people with kidney disease

Official title: Cardiovascular risk reduction in adolescents and young adults with kidney disease

Funded at University of California, San Francisco · NIH-10984341 · Data updated 2026-11-12

This study is looking at how kidney disease affects heart health in teens and young adults, especially focusing on high blood pressure, and it offers a chance for patients to help improve care for themselves and others.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$126,099
NIH project number1K24HL171861-01A1
Project IDNIH-10984341 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adolescents and young adults diagnosed with kidney disease, particularly those experiencing hypertension.

Less likely to help

Patients without kidney disease or those who are not within the adolescent to young adult age range may not benefit from this research.

What this research studies

This research focuses on understanding and improving cardiovascular health in adolescents and young adults who have kidney disease. It aims to investigate hypertension and cardiovascular outcomes, particularly how these conditions affect young patients. The study will utilize a variety of datasets and electronic health records to analyze health disparities and develop effective interventions. Patients may have the opportunity to participate in clinical assessments and contribute to research that could lead to better health management strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved cardiovascular health and management strategies for young patients with kidney disease.

How similar studies have gone: Previous research has shown promising results in addressing cardiovascular risks in patients with kidney disease, indicating that this approach has potential for success.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Ku, Elaine — University of California, San Francisco
  • Study coordinator: Ku, Elaine

Related research

Other NIH-funded projects on the same topics.

  • Eicosanoids and kidney disease link to heart risks

    This grant explores how tiny fat-derived molecules (eicosanoids) influence kidney disease and heart risk in adults.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11367536

  • Eicosanoids and Heart Risk in Chronic Kidney Disease

    This research explores how natural body chemicals called eicosanoids might connect chronic kidney disease with heart problems.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11181170

  • Investigating how eicosanoids affect kidney disease and heart health

    This study is looking at how certain tiny molecules from fats affect kidney disease and heart health in people with chronic kidney disease, hoping to find new ways to help manage these conditions better.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11000030

  • Personalized CKD-MBD care using systems biology and AI

    A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11644324

  • Cardiovascular risk planning and reduction for men with prostate cancer

    A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.

    NIH research University of Pennsylvania · Philadelphia, United States · NIH-11627340

  • Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors

    This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.

    NIH research Healthpartners Institute · Bloomington, UNITED STATES · NIH-11595907

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.